About: Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $55.21 (+0.84%)
ETON NASDAQ Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc share price
ETON price activity
Last Price
$55.210
Change (24hr)
0.46 USD (0.84%)
Volume
370.47K
Volume (4w avg)
-
Open
$54.86
Day Range
$54.20 - $56.35
Previous Close
$54.75
Last Trade
09 Oct, 8:00 pm GMT+0
Delayed
09 Oct, 8:00 pm GMT+0
ETON price performance
Delayed
09 Oct, 8:00 pm GMT+0
ETON Market Signals